Search results for "Editorial"

showing 10 items of 428 documents

Outbreak of Novel Coronavirus (SARS-Cov-2): First Evidences From International Scientific Literature and Pending Questions

2020

On 31 December, 2019, a cluster of 27 pneumonia cases of unknown etiology was reported by Chinese health authorities in Wuhan City (China) [...]

medicine.medical_specialty2019-20 coronavirus outbreakLeadership and ManagementSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:MedicineHealth InformaticsScientific literatureDisease clusterSettore MED/42 - Igiene Generale E Applicata03 medical and health sciences0302 clinical medicineHealth Information Managementmedicine030212 general & internal medicineoutbreakbusiness.industrySARS-CoV-2Health PolicyPublic healthlcsh:ROutbreakCOVID-19medicine.diseaseVirologyPneumoniaEditorialSevere acute respiratory syndrome coronavirusPublic Healthbusiness030217 neurology & neurosurgery
researchProduct

Physiological and Nutritional Roles of PPAR across Species.

2013

There has been a tremendous amount of information produced on peroxisome proliferator-activated receptors (PPARs). The interest in PPARs was originally driven largely by their role in hypolipidemia and hepatocarcinogenesis, but it soon became evident that they played important roles in the metabolic syndrome and overall health of organisms including regeneration of tissues, differentiation, insulin signaling, overall lipid metabolism, and immune response (reviewed in [1–7]). From a nutritional standpoint, the PPARs are of extreme importance because of their ability to bind and be activated by long-chain fatty acids and their metabolites. Therefore, the PPARs are recognized as ideal candidat…

medicine.medical_specialtyArticle SubjectAnimal food[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Peroxisome proliferator-activated receptorAdipose tissueContext (language use)White adipose tissueBiologyBioinformaticsEnergy homeostasis03 medical and health sciencesInternal medicineDrug Discoverymedicine[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular Biology[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Pharmacology (medical)[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biologylcsh:QH301-705.5[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyComputingMilieux_MISCELLANEOUS030304 developmental biology2. Zero hungerchemistry.chemical_classification[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism0303 health sciences[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]0402 animal and dairy scienceLipid metabolism04 agricultural and veterinary sciences[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism040201 dairy & animal scienceNutrigenomicsEndocrinologyEditoriallcsh:Biology (General)chemistry
researchProduct

PPAR in Cardiovascular Disorders

2016

Peroxisome proliferation-activated receptors (PPARs) are ligand-inducible transcription factors that, upon binding their ligands, translocate into the nucleus, where they regulate transcription of numerous genes that have the peroxisome proliferator response element (PPRE) in the promoter region [1]. In humans, there are 3 PPAR isoforms: PPAR-α, PPAR-β/δ, and PPAR-γ. The isoforms have partially overlapping spectra of activity and are differently expressed in organs and tissues [2]. PPAR-α is expressed mostly in tissues characterized by high catabolic activity, including skeletal muscle, liver, proximal tubular cells in kidneys, and brown fat. This PPAR isoform regulates components of β-oxid…

medicine.medical_specialtyArticle SubjectPeroxisome proliferator-activated receptor030209 endocrinology & metabolism030204 cardiovascular system & hematologyBiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDownregulation and upregulationInternal medicineDrug DiscoverymedicineGlucose homeostasisPharmacology (medical)Beta oxidationlcsh:QH301-705.5chemistry.chemical_classificationFatty acid metabolismLipid metabolismPeroxisomeEndocrinologyEditorialchemistrylcsh:Biology (General)Rosiglitazonemedicine.drugPPAR Research
researchProduct

Medicinal plants in the prevention and treatment of chronic diseases 2013.

2014

Since the dawn of human civilization, human beings have found remedies within their habitat and have adopted different therapeutic strategies depending upon climatic, phytogeographic, sociocultural, floral, and faunal characteristics. Traditional systems thus contain beliefs and practices in order to avoid, prevent, or avert ailments, which constitute traditional preventive medicine. The use of medicinal herbs and herbal medicine is an age-old tradition and the recent progress in modern therapeutics has stimulated the use of natural product worldwide for diverse ailments and diseases. The educated public and health care professionals have enormous interests in the medicinal uses of herbs, b…

medicine.medical_specialtyArticle SubjectTraditional medicinebusiness.industryAlternative medicineMEDLINElcsh:Other systems of medicinelcsh:RZ201-999NutraceuticalPharmacotherapyEditorialComplementary and alternative medicineHealth careMedicineIdentification (biology)businessMedicinal plantsPreventive healthcareEvidence-based complementary and alternative medicine : eCAM
researchProduct

Rehabilitation and Improvement of the Postural Function

2015

Posture refers to the position of different body segments at a given time which can be modified through joint mobilization and the action of the neuromuscular system. Maintaining balance during bipedal quiet stance requires complex mechanisms from the postural control system in order to keep the vertical projection of the centre of mass (COM) within the base of support [1]. To achieve this aim, the centre of pressure (COP) plays a crucial role to compensate for any deviations of the COM, which can generate imbalance if they move beyond the limits of the base of support. The ability to control the COM depends on internal body representation in space. Internal representation is acquired by me…

medicine.medical_specialtyArticle Subject[SDV]Life Sciences [q-bio]Posturelcsh:MedicineSensory systemMotor programGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesMuscle tone0302 clinical medicinePhysical medicine and rehabilitationmedicinePostural BalanceHumansExercisePostural BalanceMotor skillComputingMilieux_MISCELLANEOUSVestibular systemSensory stimulation therapyGeneral Immunology and MicrobiologyProprioceptionRehabilitationlcsh:R030229 sport sciencesGeneral MedicineEditorialmedicine.anatomical_structurePhysical therapy[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Psychology030217 neurology & neurosurgery
researchProduct

Does aspirin save lives in patients with COVID-19?

2021

‘An aspirin a day keeps the heart attack away’, is this also true in the prevention of thrombotic events associated with COVID-19? The rising COVID-19 pandemic has led to much work in the understanding of the pathophysiology of the disease. COVID-19 infection is thought to be an endothelial disease. Supporting this concept, it has been suggested that infection with SARS-CoV-2, the aetiological agent for COVID-19 infection, leads to a state mimicking Virchow’s triad, that is, vascular endothelial injury, blood stasis and clotting in concert with systemic inflammation resulting in systemic thrombosis. In keeping with this concept, moderately and critically ill patients with COVID-19 have been…

medicine.medical_specialtyAspirin2474business.industryCOVID-19healthcareInflammationDiseaseBlood stasisSystemic inflammationmedicine.diseaseThrombosisEditorialmedicineEtiologyPlatelet activationmedicine.symptomCardiology and Cardiovascular MedicineIntensive care medicinebusinessoutcome assessmentmedicine.drugHeart
researchProduct

Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw

2014

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious complication associated with oral and intravenous bisphosphonate therapy that adversely affects the quality of life, producing significant morbidity. Since the first description of bone necrosis in patients receiving bisphosphonate therapy in 2003 [1], hundreds of studies were published about this topic and various national and international medical societies have published protocols and guidelines. Nevertheless, there are still many controversies regarding the classification, management, and prevention of BRONJ. Even the definition of BRONJ is still debated and changed with the progress of knowledge and experience. Accord…

medicine.medical_specialtyBisphosphonate-associated osteonecrosis of the jawArticle Subjectbusiness.industrymedicine.medical_treatmentRetrospective cohort studyBisphosphonatemedicine.diseaseReview articleSurgeryBisphosphonate Osteonecrosis of the Jawlcsh:RK1-715EditorialDenosumablcsh:DentistryOral and maxillofacial pathologymedicineOral and maxillofacial surgeryIntensive care medicineOsteonecrosis of the jawbusinessGeneral Dentistrymedicine.drugInternational Journal of Dentistry
researchProduct

SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?

2021

Since the dramatic rise of the coronavirus infection disease 2019 (COVID-19) pandemic, patients receiving dialysis have emerged as especially susceptible to this infection because of their impaired immunologic state, chronic inflammation and the high incidence of comorbidities. Although several strategies have thus been implemented to minimize the risk of transmission and acquisition in this population worldwide, the reported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence varies across studies but is higher than in the general population. On the contrary, the screening for hepatitis viruses (HBV and HCV) has seen significant improvements in recent years, with va…

medicine.medical_specialtyCOVID19Health Toxicology and Mutagenesismedicine.medical_treatmentPopulation030232 urology & nephrologymedicine.disease_cause03 medical and health sciences0302 clinical medicineRenal DialysisSeroepidemiologic StudiesPandemicHepatitis VirusesmedicineSeroprevalenceHumanshepatitisIntensive care medicineeducationCoronavirusHepatitiseducation.field_of_studybusiness.industryTransmission (medicine)SARS-CoV-2RPublic Health Environmental and Occupational Healthvirus diseasesCOVID-19medicine.diseaseVaccinationEditorialMedicinedialysis030211 gastroenterology & hepatologyHemodialysisbusinesschronic kidney diseaseInternational Journal of Environmental Research and Public Health
researchProduct

Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis.

2021

Abstract Aim To estimate the mortality rate, the rate of return of spontaneous circulation (ROSC) and survival with favorable neurological outcome in patients with COVID-19 after in-hospital cardiac arrest (IHCA) and attempted cardiopulmonary resuscitation (CPR). Methods PubMed, EMBASE, Web of Science, bioRxiv and medRxiv were surveyed up to 8th February 2021 for studies reporting data on mortality of patients with COVID-19 after IHCA. The primary outcome sought was mortality (in-hospital or at 30 days) after IHCA with attempted CPR. Additional outcomes were the overall rate of IHCA, the rate of non-shockable presenting rhythms, the rate of ROSC and the rate of survival with favorable neuro…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.medical_treatment030204 cardiovascular system & hematologyEmergency Nursing03 medical and health sciences0302 clinical medicinePrimary outcomeInternal medicineHospital dischargeMedicineHumansIn patientcprCardiopulmonary resuscitationMortalitybusiness.industrySARS-CoV-2Neurological statusMortality rateCOVID-19030208 emergency & critical care medicineCardiac arrestCardiopulmonary ResuscitationHospitalsHeart ArrestEditorialMeta-analysisEmergency MedicineCardiology and Cardiovascular MedicinebusinessResuscitation
researchProduct

The global challenge of Candida auris in the intensive care unit

2019

Since the first isolation of Candida auris in 2009, scientific community has witnessed an exponential emergence of infection episodes and outbreaks in different world regions. It is hard to predict future C. auris diffusion. By now, global surveillance, improving knowledge, and taking care of the A.U.R.I.S. major issues may be the best ways to face C. auris challenge

medicine.medical_specialtyCritical Care Intensive Care Medicine Candida aurisbusiness.industryIatrogenic DiseaseMEDLINElcsh:Medical emergencies. Critical care. Intensive care. First aidCandidiasisCandida; Candidiasis; Global Health; Humans; Iatrogenic Disease; Intensive Care Unitslcsh:RC86-88.9Critical Care and Intensive Care MedicineGlobal HealthIntensive care unitlaw.inventionIntensive Care UnitsEditorialCandida aurislawMedicineHumansbusinessIntensive care medicineCandidaCritical Care
researchProduct